Log in

Hemispherx BioPharma Insider Trading Activity (NYSEAMERICAN:HEB)

$1.96
0.00 (0.00 %)
(As of 09/6/2019)
Today's Range
$1.90
Now: $1.96
$2.06
50-Day Range N/A
52-Week Range
$1.69
Now: $1.96
$14.81
Volume111,364 shs
Average Volume102,599 shs
Market Capitalization$4.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

Hemispherx BioPharma (NYSEAMERICAN:HEB) Insider Buying and Selling Activity

Hemispherx BioPharma (NYSEAMERICAN HEB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2019Thomas K EquelsInsiderBuy2,632$4.37$11,501.8463,041  
6/21/2019Thomas K EquelsInsiderBuy29,404$4.03$118,498.121,393,611  
6/21/2019Wayne S. SpringateVPBuy5,211$4.03$21,000.33  
6/21/2019William M MitchellDirectorBuy9,677$4.03$38,998.3120,838  
3/19/2019Thomas K EquelsInsiderBuy13,400$0.18$2,412.00811,707  
11/30/2018Thomas K EquelsInsiderBuy20,000$0.19$3,800.00779,661  
11/5/2018Stewart AppelrouthDirectorBuy25,238$0.22$5,552.36266,988  
10/25/2018Thomas K EquelsCEOBuy100,000$0.20$20,000.00772,307  
7/27/2018Thomas K EquelsCEOBuy34,483$0.29$10,000.07672,306  
7/24/2018Stewart AppelrouthDirectorBuy126,000$0.31$39,060.00241,750  
7/23/2018Thomas K EquelsInsiderBuy112,904$0.31$35,000.24637,823  
7/23/2018Wayne S SpringateVPBuy32,259$0.31$10,000.2964,773  
4/27/2018Stewart AppelrouthDirectorBuy100,000$0.32$32,000.00115,750  
4/27/2018Thomas K EquelsCEOBuy32,000$0.32$10,240.00524,919  
5/2/2017Adam PascaleCFOBuy15,873$0.63$9,999.9927,389  
5/2/2017David R StrayerInsiderBuy7,937$0.63$5,000.3141,804  
4/27/2017Thomas K EquelsCEOBuy72,464$0.69$50,000.16492,919  
4/11/2017Thomas K EquelsCEOBuy200,000$0.50$100,000.00420,455  
2/16/2017Adam PascaleCFOBuy6,981$0.46$3,211.2611,516  
2/16/2017David R StrayerInsiderBuy9,892$0.46$4,550.3233,867  
2/16/2017Wayne S SpringateSVPBuy8,014$0.46$3,686.4431,989  
12/22/2016Thomas K EquelsCEOBuy68,493$0.73$49,999.89220,455  
11/1/2016Thomas K EquelsCEOBuy10,000$1.00$10,000.00151,962  
7/8/2016Thomas K EquelsCEOBuy48,000$0.12$5,760.001,703,548  
7/1/2016Thomas K EquelsCEOBuy171,000$0.12$20,520.001,514,548  
3/18/2016Thomas K EquelsCEOBuy30,000$0.13$3,900.001,484,548  
3/11/2016Thomas K EquelsCEOBuy40,000$0.16$6,400.001,444,548  
3/10/2016Thomas K EquelsCEOBuy30,000$0.16$4,800.0030,000  
8/20/2015William A CarterCEOBuy25,000$0.18$4,500.001,225,585  
8/18/2015William A CarterCEOBuy25,000$0.18$4,500.001,200,585  
8/17/2015William A CarterCEOBuy25,000$0.18$4,500.00  
8/14/2015Thomas K EquelsCFOBuy79,104$0.18$14,238.72  
4/28/2015William A CarterCEOBuy100,000$0.24$24,000.00  
4/27/2015Thomas K EquelsCFOBuy100,000$0.24$24,000.00  
4/21/2015William A CarterCEOBuy100,000$0.24$24,000.00  
4/20/2015Thomas K EquelsCFOBuy100,000$0.24$24,000.00  
4/17/2015William A CarterCEOBuy73,681$0.23$16,946.63  
4/16/2015William A CarterCEOBuy26,319$0.23$6,053.37  
4/15/2015Thomas K EquelsCFOBuy100,000$0.23$23,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel